Early last year, startup iECURE’s experimental gene therapy seemingly cured a baby of a life-threatening genetic disease. But new results testing the same therapy in a larger number of babies show that such miraculous outcomes are no guarantee.
BOSTON — Early last year, startup iECURE’s experimental gene therapy seemingly cured a baby of a life-threatening genetic disease.
But new results testing …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Scientists link boy’s tumor to gene therapy viruses, in rare finding
Five years after disaster, a rare disease community gets new chance at treatment
Capsida says it still doesn’t know what caused gene therapy death
Drug meant to make gene therapy safer may also make it less effective
With new data, Regenxbio to seek FDA approval of Duchenne gene therapy
“We’re still very much in the early stages,” a gene therapy expert said. “But every day, he’s showing us signs that he’s growing…
Doctors have linked a boy's tumor to a gene therapy, but say the rare risks need to be weighed against the profound benefits such…
Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a…
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of editing…
At the WIRED Health summit, pioneer David Liu said his lab is on the verge of revealing a new gene-editing technique that could…
Editorial: Cutting-edge therapies exist, but the market cannot deliver them cheaply. Britain must build NHS capacity so that…
